MAIA Biotechnology, Inc. General form of registration statement for all companies including face-amount certificate companies

General form of registration statement for all companies including face-amount certificate companies

Fair Value of Financial Liabilities (Tables)

Fair Value of Financial Liabilities (Tables)

12 Months Ended

Dec. 31, 2021

Schedule of Fair Value Measurements of Embedded Derivative Liabilities and Warrant Liabilities

The fair values of the embedded derivative liabilities and warrant liabilities recorded are as follows:

	Fair value at September 30, 2021
	Total		Level 1		Level 2		Level 3
Liabilities:
Derivative liability, bifurcated put contained in convertible notes payable	$	—	$	—	$	—	$	—
Warrant liability		—		—		—		—
Total liabilities	$	—	$	—	$	—	$	—

	Fair value at December 31, 2020
	Total		Level 1		Level 2		Level 3
Liabilities:
Derivative liability, bifurcated put contained in convertible notes payable	$	127,000	$	—	$	—	$	127,000
Warrant liability		85,260		—		—		85,260
Total liabilities	$	212,260	$	—	$	—	$	212,260

Schedule of Changes in Fair Value of the Derivative Liabilities and Warrant Liabilities

The table below provides a summary of the changes in fair value of the derivative liabilities and warrant liabilities measured on a recurring basis using significant unobservable inputs (Level 3):

	Year Ended December 31,
Derivative liabilities:	2021			2020
Balance, beginning of period	$	127,000		$	1,000
Derivative liability on convertible notes payable		2,821,000			131,000
Loss (Gain) on fair value of embedded features		203,000			(5,000	)
Extinguishment of derivative liability in connection with debt conversion		(3,151,000	)		—
Balance, end of period	$	—		$	127,000

	Year Ended December 31,
Warrant liabilities:	2021			2020
Balance, beginning of period	$	85,260		$	—
Warrant liability		320,460			65,660
Loss on fair value of warrant liability		1,546,280			19,600
Reclassification of warrant liability to equity		(1,952,000	)		—
Balance, end of period	$	—		$	85,260